Filing metadata

Accession number
0001140361-22-023928
Form type
Form 4
Filer
Ernexa Therapeutics Inc.
CIK
CIK 748592
Filed
Jun 23, 2022
Reporting period
Jun 21, 2022
Description
Insider transaction

Explore SEC Filings Hub